Skip to main content

Escalon Medical Corp.

corporate_fare Company Profile

Escalon Medical Corp.

ESMC·OTC·Industrial Applications And Services·CIK 0000862668

Escalon Medical Corp. is a Pennsylvania corporation, initially incorporated in California in 1987 and reincorporated in Pennsylvania in November 2001. The company operates in the healthcare market, focusing on the development, manufacture, marketing, and distribution of medical devices for ophthalmic applications. Escalon includes its division "Trek" and its wholly-owned subsidiaries: Sonomed, Inc., Escalon Digital Solutions, Inc. (EMI), and Sonomed IP Holdings, Inc. The company's products are subject to regulation and inspection by the United States Food and Drug Administration (FDA) and other government authorities, which require extensive testing of new products before sale and have jurisdiction over product safety, efficacy, manufacture, labeling, and marketing. Escalon's product offerings include A-Scans, which provide information about the internal structure of the eye by sending an ultrasound beam along a fixed axis. This system displays the position and magnitudes of echoes from surfaces like the cornea, lens, and retina, and includes software for measuring distances within the eye, primarily used to calculate lens power for implants. The company also offers B-Scans, a diagnostic tool for physicians when the media within the eye are cloudy or opaque. Unlike light, the ultrasound beam can pass through opacities to display an image of the eye's internal structures. The B-Scan transducer swings through a 60-degree sector to provide a two-dimensional image. Additionally, Escalon provides UBM (Ultrasound Biomicroscopy) devices, which are high-frequency/high-resolution ultrasound devices designed to offer detailed information about the anterior segment of the eye.

Escalon Medical Corp. (OTC:ESMC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 5 items for ESMC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for ESMC spans 10-Q, 10-K, 8-K.

Recent high-impact activity:

  • Escalon Swings to $269K Q1 Profit on 38.8% Revenue Growth; Material Weakness Persists
  • Escalon Medical 10-K: $3M AXIS Sale Drives Profit, But Material Weakness Persists
  • Asset Sale Boosts Cash, But Going Concern Warning Persists Amid Revenue Decline
  • Going Concern Warning Amidst Losses, Offset by $3M Asset Sale and Material Control Weakness
  • Escalon Medical Completes $3M AXIS Platform Sale, Receives $1M Initial Payment

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$12.74M
Net Income
$4.01M
Diluted EPS
$0.27
Op. Cash Flow
-$402.6K
Free Cash Flow
-$407.02K
Gross Profit
$5.57M
Operating Income
$45.23K
Cash & Equivalents
$3.07M
Debt / Equity
0.00×
Net Margin
31.5%
Shares Outstanding
7.42M sh
Source: 10-K · filed 2026-10-13 · accession 0001628280-26-065683

Short Interest & Short Volume

25.27 days to cover

FINRA reported short interest of 82,923 shares in ESMC as of the October 30, 2026 settlement, unchanged from the prior period — about 25.3 days to cover at its recent average daily volume. On November 20, 2026, 93.8% of ESMC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)82,923 shares as of October 30, 2026
Change vs prior period 0.0%
Days to cover25.27 at avg daily volume of 3,282
Daily short volume (FINRA facilities)93.8% of 3,093 shares on November 20, 2026
3-day average short volume91.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with E →
$0.23 +13.58% today
52-week range · as of 2026-11-16 $0.1001 – $0.4625
Market cap
$1.71M
Volume
3.1K (0.2× avg)
3-mo avg 16.7K
Live data · 2026-11-22 05:09 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ESMC - Latest Insights

ESMC
Nov 16, 2026, 4:52 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1764
Real-time Price: $0.230 info
Change: +$0.0536 (+30%) info
Market Cap: $1.706M info
ESMC
Oct 13, 2026, 4:00 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.165
Real-time Price: $0.230 info
Change: +$0.065 (+39%) info
Market Cap: $1.706M info
ESMC
May 15, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.2507
Real-time Price: $0.230 info
Change: -$0.0207 (-8%) info
Market Cap: $1.706M info
ESMC
Feb 17, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1722
Real-time Price: $0.230 info
Change: +$0.0578 (+34%) info
Market Cap: $1.706M info
ESMC
Jan 29, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.160
Real-time Price: $0.230 info
Change: +$0.070 (+44%) info
Market Cap: $1.706M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets